Motor Neurone Disease Trial, Recruiting (NCT03217396)

Motor Neurone Disease Trial, Recruiting NCT03217396 Sponsor: Neuromed IRCCS Condition: Motor Neurone Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03217396 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Motor Neurone Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 65 years old (male or female)
You have been diagnosed with Multiple Sclerosis (MS) according to a specific set of medical guidelines called the McDonald 2010 criteria
Your level of disability, measured on a standard MS scale (called the EDSS), falls between 0 and 5.5, meaning mild to moderate disability
You are able to understand and sign a consent form agreeing to take part in the study

Who may not be able to join:

You are unable to read, understand, or sign a written consent form
Your routine blood test results are outside the normal range (confirm with trial site)
You are currently pregnant or breastfeeding
You have a reason why you cannot safely have an MRI scan using a contrast dye called gadolinium (for example, certain allergies or kidney problems)
You have other serious health conditions alongside MS, other long-term diseases affecting the nervous system, or certain hidden (latent) viral infections

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Diego Centonze, MD, IRCCS Neuromed

Phone: +39 3934444159

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03217396

Sponsor: Neuromed IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Motor Neurone Disease

Trial contact: +39 3934444159

More information: https://clinicaltrials.gov/study/NCT03217396

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 65 years old (male or female)
You have been diagnosed with Multiple Sclerosis (MS) according to a specific set of medical guidelines called the McDonald 2010 criteria
Your level of disability, measured on a standard MS scale (called the EDSS), falls between 0 and 5.5, meaning mild to moderate disability
You are able to understand and sign a consent form agreeing to take part in the study

Who may not be able to join:

You are unable to read, understand, or sign a written consent form
Your routine blood test results are outside the normal range (confirm with trial site)
You are currently pregnant or breastfeeding
You have a reason why you cannot safely have an MRI scan using a contrast dye called gadolinium (for example, certain allergies or kidney problems)
You have other serious health conditions alongside MS, other long-term diseases affecting the nervous system, or certain hidden (latent) viral infections

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Neuromed IRCCS

Registry

ClinicalTrials.gov

Start date

22 November 2017

Est. completion

1 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Identification of predictive biomarkers of SM using an ex vivo chimeric model

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov